Reassurance outcomes 1 month post-disclosure according to genetic test results
| Outcomes | Carriers (a) | Noncarriers (b) | Inconclusive (c) | P* | Group differences† | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | ||||||||
| Cancer risk | ||||||||||
| Very low | 2 (3) | 13 (10) | 19 (9) | <0.0001 | a > b; a > c; b < c | |||||
| Low | 4 (5) | 33 (26) | 32 (15) | |||||||
| Moderate | 23 (30) | 62 (50) | 91 (44) | |||||||
| High | 27 (35) | 16 (13) | 52 (25) | |||||||
| Very high | 21 (27) | 1 (1) | 13 (6) | |||||||
| Lifetime cancer risk perception (%) | ||||||||||
| Mean ± SD | 53.4 ± 23.4 | 30.4 ± 21.8 | 38.0 ± 24.1 | <0.0001 | a > b; a > c; b < c | |||||
| Cancer worry | ||||||||||
| A lot less than before | 1 (1) | 52 (42) | 46 (22) | <0.0001 | a > b; a > c; b < c | |||||
| A little less than before | 3 (4) | 28 (22) | 37 (17) | |||||||
| Neither more nor less | 49 (62) | 44 (35) | 127 (60) | |||||||
| A little more than before | 21 (27) | 1 (1) | 3 (1) | |||||||
| A lot more than before | 5 (6) | 0 (0) | 0 (0) | |||||||
| Relief | ||||||||||
| Not at all | 48 (50) | 5 (4) | 40 (17) | <0.0001 | a < b; b > c | |||||
| Low | 6 (6) | 21 (16) | 54 (22) | |||||||
| Moderate | 22 (23) | 30 (23) | 61 (25) | |||||||
| Considerable | 20 (21) | 73 (57) | 86 (36) | |||||||
| Painfulness | ||||||||||
| Not painful at all | 43 (44) | 120 (94) | 220 (91) | <0.0001 | a > b; a > c | |||||
| Slightly painful | 31 (32) | 3 (2) | 16 (7) | |||||||
| Moderately painful | 18 (19) | 5 (4) | 5 (2) | |||||||
| Very painful | 5 (5) | 0 (0) | 2 (1) | |||||||
| Quality of life | ||||||||||
| Decreased a lot | 0 (0) | 0 (0) | 2 (1) | 0.0019 | a < b; b > c | |||||
| Slightly decreased | 8 (8) | 0 (0) | 0 (0) | |||||||
| The same | 79 (81) | 99 (78) | 207 (85) | |||||||
| Slightly improved | 8 (8) | 9 (7) | 20 (8) | |||||||
| Improved a lot | 2 (2) | 19 (15) | 15 (6) | |||||||